Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
5 Patents
#528 in Wilmington, DE
#732 in Delaware
#51,570 in US
Omthera Pharmaceuticals Inc.
Forward Citations = 28
15 inventors:
Wilmington, DE, United States of America
Omthera Pharmaceuticals Inc.
% Expired Patents = 100.0
CIPO Patents = 2
EPO Patents = 1
Forward Citations = 28
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Michael H Davidson (4 out of 10 patents)
Timothy J Maines (4 out of 4 patents)
Bharat M Mehta (4 out of 4 patents)
4. Gerald L Wisler (3 out of 3 patents)
5. Peter Ralph Wood (3 out of 3 patents)
6. Bernardus Nicolaas Machielse (2 out of 46 patents)
7. Bernardus N M Machielse (2 out of 2 patents)
8. Hironori Kubota (1 out of 4 patents)
9. Etienne Thierry Charles Rogeau (1 out of 1 patent)
10. Julien Georges Meissonnier (1 out of 1 patent)
11. Tohru Amemiya (1 out of 1 patent)
12. Anders Gillis Holmén (1 out of 1 patent)
13. Andreas Rådevik (1 out of 1 patent)
14. Bengt Staffan Schantz (1 out of 1 patent)
15. Hans Carlsson (1 out of 2 patents)
5 patents:
Company Overview
Omthera Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. The company's flagship product is Epanova, a prescription omega-3 fatty acid that helps reduce triglyceride levels in patients with severe hypertriglyceridemia. With a dedication to improving patient outcomes and a commitment to innovation, Omthera is poised to make a positive impact in the healthcare industry.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Omthera Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/omthera-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]